LENSAR, Inc. (LNSR) Reports Q4 Loss of $0.78 on Revenues of $8.28M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
LENSAR Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
March 10, 2021 7:00 AM ESTFourth Quarter 2020 Procedure Volumes Consistent with Fourth Quarter 2019 Levels
Cash and Cash Equivalents of $40.6 Million as of December 31, 2020
ORLANDO, Fla.--(BUSINESS WIRE)-- LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the fourth quarter and full year ended December 31, 2020 and provided an update on key strategic and operational initiatives.
2020 was a transformative year for LENSAR, said Nick Curtis, Chief Executive Officer of... More
